These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19884855)

  • 1. Verification of the newly proposed T category (seventh edition of the tumor, node, and metastasis classification) from a clinicopathological viewpoint in non-small cell lung cancer-special reference to tumor size.
    Yano T; Morodomi Y; Ito K; Yoshida T; Haro A; Shoji F; Koga T; Maehara Y
    J Thorac Oncol; 2010 Jan; 5(1):45-8. PubMed ID: 19884855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral pleural invasion classification in non-small-cell lung cancer in the 7th edition of the tumor, node, metastasis classification for lung cancer: validation analysis based on a large-scale nationwide database.
    Kawase A; Yoshida J; Miyaoka E; Asamura H; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Sawabata N; Okumura M; Yokoi K;
    J Thorac Oncol; 2013 May; 8(5):606-11. PubMed ID: 23478542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of the presence of microscopic vascular invasion after complete resection of Stage I-II pT1-T2N0 non-small cell lung cancer and its relation with T-Size categories: did the 2009 7th edition of the TNM staging system miss something?
    Ruffini E; Asioli S; Filosso PL; Buffoni L; Bruna MC; Mossetti C; Solidoro P; Oliaro A
    J Thorac Oncol; 2011 Feb; 6(2):319-26. PubMed ID: 21164365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the proposals of the international association for the study of lung cancer in the forthcoming edition of lung cancer staging system to predict long-term prognosis of operated patients.
    Rena O; Massera F; Robustellini M; Papalia E; Delfanti R; Lisi E; Pirondini E; Turello D; Casadio C
    Cancer J; 2010; 16(2):176-81. PubMed ID: 20404615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer - Lung Cancer Staging Project: a validation study from a single-centre experience.
    Ruffini E; Filosso PL; Bruna MC; Coni F; Cristofori RC; Mossetti C; Solidoro P; Oliaro A
    Eur J Cardiothorac Surg; 2009 Dec; 36(6):1037-44. PubMed ID: 19692259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral pleural invasion classification in non-small cell lung cancer.
    Kawase A; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
    J Thorac Oncol; 2010 Nov; 5(11):1784-8. PubMed ID: 20881646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
    Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
    J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of tumor size eliminating the ground glass opacity component: modified clinical T descriptors of the tumor, node, metastasis classification of lung cancer.
    Nakamura S; Fukui T; Taniguchi T; Usami N; Kawaguchi K; Ishiguro F; Hirakawa A; Yokoi K
    J Thorac Oncol; 2013 Dec; 8(12):1551-7. PubMed ID: 24389437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Size of Stage IIIA primary lung cancers and survival: a surveillance, epidemiology and end results database analysis.
    Maximus S; Nguyen DV; Mu Y; Calhoun RF; Cooke DT
    Am Surg; 2012 Nov; 78(11):1232-7. PubMed ID: 23089441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The revised TNM staging system for lung cancer.
    Rami-Porta R; Crowley JJ; Goldstraw P
    Ann Thorac Cardiovasc Surg; 2009 Feb; 15(1):4-9. PubMed ID: 19262443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer.
    Rami-Porta R; Ball D; Crowley J; Giroux DJ; Jett J; Travis WD; Tsuboi M; Vallières E; Goldstraw P; ; ; ;
    J Thorac Oncol; 2007 Jul; 2(7):593-602. PubMed ID: 17607114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new tumor, node, and metastasis staging system.
    Rami-Porta R; Bolejack V; Goldstraw P
    Semin Respir Crit Care Med; 2011 Feb; 32(1):44-51. PubMed ID: 21500123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of intratumoural microvascular invasion and microlymphatic permeation on node-negative non-small-cell lung cancer: which indicator is the stronger prognostic factor?
    Hishida T; Yoshida J; Maeda R; Ishii G; Aokage K; Nishimura M; Nagai K
    Eur J Cardiothorac Surg; 2013 Apr; 43(4):772-7. PubMed ID: 22864791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The new TNM classification in lung cancer].
    Wrona A; Jassem J
    Pneumonol Alergol Pol; 2010; 78(6):407-17. PubMed ID: 21077033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of proton therapy and carbon-ion therapy for large (T2a-T2bN0M0) non-small-cell lung cancer.
    Iwata H; Demizu Y; Fujii O; Terashima K; Mima M; Niwa Y; Hashimoto N; Akagi T; Sasaki R; Hishikawa Y; Abe M; Shibamoto Y; Murakami M; Fuwa N
    J Thorac Oncol; 2013 Jun; 8(6):726-35. PubMed ID: 23459403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution.
    Kameyama K; Takahashi M; Ohata K; Igai H; Yamashina A; Matsuoka T; Nakagawa T; Okumura N
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1180-4. PubMed ID: 19379988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
    Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
    J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the new lung cancer staging system for a predominantly advanced-disease patient population.
    Chien CR; Yang ST; Chen CY; Fang HY; Tu CY; Tseng GC; Yu YH; Chen HJ; Ho CT; Hsieh CY; Chen HN; Chen PR; Liu JC; Wang YC; Wu HH; Hsia TC
    J Thorac Oncol; 2010 Mar; 5(3):340-3. PubMed ID: 20186024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposal on incorporating blood vessel invasion into the T classification parts as a practical staging system for stage I non-small cell lung cancer.
    Kudo Y; Saji H; Shimada Y; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Lung Cancer; 2013 Aug; 81(2):187-93. PubMed ID: 23664031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T2 tumors larger than five centimeters in diameter can be upgraded to T3 in non-small cell lung cancer.
    Carbone E; Asamura H; Takei H; Kondo H; Suzuki K; Miyaoka E; Tsuchiya R; Motta G
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):907-12. PubMed ID: 11689795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.